GMP

HFR have been inspected by the MHRA and are in compliance with the principles and guidelines of good manufacturing practice as regulated by ICH Q7 and Eudralex volume 4 part II for clinical trials.

Our facilities include two segregated ISO Class 8 laboratories in which multi-stage synthesis to cGMP standards is carried out. Each facility operates at a 30 liter scale, typically enabling production in batches of up to multi kilo quantities. HFR are capable of cytotoxic and non-cytotoxic manufacture.